Skip to main content

What the FDA labels say about taking them together

Drospirenone/estetrol and lamotrigine

Drospirenone/estetrol's FDA label of May 11, 2023 names lamotrigine in its drug interactions section; the lamotrigine labels PlainMeds reads (3) do not name drospirenone/estetrol. The drospirenone/estetrol label: “Lamotrigine Clinical Effect Concomitant use of NEXTSTELLIS may decrease lamotrigine exposure, which may reduce efficacy of lamotrigine.”

Check it at the source: the drospirenone/estetrol FDA label on DailyMed (effective May 11, 2023); the lamotrigine FDA label on DailyMed (effective October 10, 2025).

What does the drospirenone/estetrol label say about lamotrigine?

Drospirenone/estetrol label, drug interactions

Lamotrigine Clinical Effect Concomitant use of NEXTSTELLIS may decrease lamotrigine exposure [see Clinical Pharmacology (12.3) ], which may reduce efficacy of lamotrigine.

Source: FDA drug label (Nextstellis), Mayne Pharma, effective May 11, 2023 (SPL set c5270073-d083-4109-ae4b-156986175e0a), via openFDA; the full label on DailyMed

What does the lamotrigine label say about drospirenone/estetrol?

Lamotrigine's label (effective October 10, 2025) and its 2 other brand-application labels do not name drospirenone/estetrol in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (LAMICTAL), GlaxoSmithKline LLC, effective October 10, 2025 (SPL set d7e3572d-56fe-4727-2bb4-013ccca22678), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Drospirenone/estetrol generic labelers
49Lamotrigine generic labelers
Drospirenone/estetrolLamotrigine
Labeled forBirth controlSeizures and epilepsy, Bipolar disorder
Boxed warningYesYes
Pharmacy cost (NADAC)$7.67 per tablet 3-14.2 mg tablet$0.0268 per tablet 25 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?